Age, Biography and Wiki

Stephen K. Burley was born on 1958 in Canada. Discover Stephen K. Burley's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 65 years old?

Popular As N/A
Occupation N/A
Age 65 years old
Zodiac Sign
Born 1958, 1958
Birthday 1958
Birthplace N/A
Nationality Canada

We recommend you to check the complete list of Famous People born on 1958. He is a member of famous with the age 65 years old group.

Stephen K. Burley Height, Weight & Measurements

At 65 years old, Stephen K. Burley height not available right now. We will update Stephen K. Burley's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Stephen K. Burley Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Stephen K. Burley worth at the age of 65 years old? Stephen K. Burley’s income source is mostly from being a successful . He is from Canada. We have estimated Stephen K. Burley's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income

Stephen K. Burley Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2012

In 2012 Burley joined Rutgers as Director of the Center for Integrative Proteomics Research and became director of the RCSB PDB (US regional data center for the worldwide PDB) in 2014, succeeding Prof. Helen Berman

2008

He worked with Gregory A. Petsko and William N. Lipscomb at MIT and Harvard. He was faculty at Howard Hughes Medical Institute and Rockefeller University. Burley co-founded Prospect Genomics, Inc, a computational genomics pharma. He was Chief Scientific Officer of SGX Pharmaceuticals after it acquired Prospect. SGX was in turn merged with Eli Lilly in 2008 where Burley was a Distinguished Lilly Research Scholar in Lilly Research Laboratories